ALPL Antikörper
Kurzübersicht für ALPL Antikörper (ABIN6654223)
Target
Alle ALPL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Purified
-
Reinheit
- Protein G affinity chromatography
-
Immunogen
- Alkaline Phosphatase was used as the immunogen for the ALPL antibody.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Optimal dilution of the ALPL antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the ALPL antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- ALPL (Alkaline Phosphatase, Liver/bone/kidney (ALPL))
-
Andere Bezeichnung
- Alkaline Phosphatase / ALPL
-
Hintergrund
- There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. The exact physiological function of the alkaline phosphatases is not known. A proposed function of this form of the enzyme is matrix mineralization, however, mice that lack a functional form of this enzyme show normal skeletal development. This enzyme has been linked directly to hypo-phosphatasia, a disorder that is characterized by hypercalcemia and includes skeletal defects. The character of this disorder can vary, however, depending on the specific mutation since this determines age of onset and severity of symptoms. Alternatively spliced transcript variants, which encode the same protein, have been identified for this gene.
Target
-